Von Willebrand factor in synovial fluid: a comment
Blann, A.D.
Clinical and Experimental Rheumatology 10(3): 322-323
1992
ISSN/ISBN: 0392-856X PMID: 1582082 Document Number: 394221
Document emailed within 1 workday
Related Documents
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Kanety, H.; Shimon, I.; Ehrenfeld, M.; Israeli, A.; Pariente, C.; Karasik, A. 1996: Insulin-like growth factor I and its binding proteins 3 and 4 are increased in Human inflammatory synovial fluid Journal of Rheumatology 23(5): 815-818
Webb, J.; Peart, M.B.; Robinson, R.G. 1971: Rheumatoid factor testing of serum and synovial fluid, with comparative evaluation of a new haemagglutination test Medical Journal of Australia 2(13): 660-662
Takei, I.; Takagi, M.; Ida, H.; Ogino, T.; Santavirta, S.; Konttinen, Y.T. 2000: High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints Journal of Rheumatology 27(4): 894-899
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Souteyrand-Boulenger, J.D.; Amouroux, J. 1972: Synovial membrane and synovial fluid in normal and pathological states. 2. Functions of the synovial membrane La Nouvelle Presse Medicale 1(6): 401-406
Painter, P.C.; Lyon, J.M.; Evans, J.H.; Powers, W.W.; Whittaker, R.L.; Decker, M.J. 1982: Performance of a new rate-nephelometric assay for rheumatoid factor, and its correlation with tube-titer results for human sera and synovial fluid Clinical Chemistry 28(11): 2214-2218
Hawkins, D.L.; Cargile, J.L.; MacKay, R.J.; Broome, T.A.; Skelley, L.A. 1995: Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin American Journal of Veterinary Research 56(10): 1292-1299
Roux-Lombard, P.; Modoux, C.; Vischer, T.; Grassi, J.; Dayer, J.M. 1992: Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cells Journal of Rheumatology 19(4): 517-523
Stiehl, P.; Geiler, G. 1974: Morphological activity estimation of rheumatoid arthritis: a comparative study of synovial fluid and synovial membrane Zeitschrift für Rheumatologie 33(1): 54-62
Kriegbaum, P.E. 1997: Volume of synovial membrane and synovial fluid determined by MR-imaging Ugeskrift for Laeger 159(33): 4998-4999